Gibson Dunn has been recognized in the 2024 edition of Chambers High Net Worth, a guide to the leading lawyers and law firms for international private wealth. Our firm achieved a top-tier ranking in China: Private Wealth Disputes. Hong Kong partners Brian Gilchrist OBE and Elaine Chen and of counsel Alex Wong were recognized in the China: Private Wealth Disputes category, and partner Michael Desmond (Los Angeles) was recognized in the USA: Private Client: Tax category. Read more here: https://lnkd.in/g9w2FEHU
About us
Gibson Dunn is a leading global law firm, advising clients on significant transactions and disputes. Our exceptional teams craft and deploy creative legal strategies that are meticulously tailored to every matter, however complex or high-stakes. With more than 1,900 lawyers, spanning 21 offices and dozens of practice areas, we operate as a unified whole. Our work is distinguished by a unique combination of precision and vision. We forge deep partnerships with our clients - helping them face tough challenges with courage and thrive in unprecedented times. © 2024 Gibson, Dunn & Crutcher LLP. All rights reserved. For contact and other information, please visit us at www.gibsondunn.com. Attorney Advertising: These materials were prepared for general informational purposes only based on information available at the time of publication and are not intended as, do not constitute, and should not be relied upon as, legal advice or a legal opinion on any specific facts or circumstances. Gibson Dunn (and its affiliates, attorneys, and employees) shall not have any liability in connection with any use of these materials. The sharing of these materials does not establish an attorney-client relationship with the recipient and should not be relied upon as an alternative for advice from qualified counsel. Please note that facts and circumstances may vary, and prior results do not guarantee a similar outcome.
- Website
-
https://www.gibsondunn.com
External link for Gibson Dunn
- Industry
- Law Practice
- Company size
- 1,001-5,000 employees
- Headquarters
- Global
- Type
- Partnership
- Specialties
- Legal Services
Locations
Employees at Gibson Dunn
Updates
-
The biggest deal of partner Andrew Kaplan’s career thus far is also the biggest technology deal ever: VMware's $90 billion acquisition by Broadcom, a complicated transaction made challenging by its scope and regulatory and global political scrutiny, and one that took 18 months to close. Speaking with Law360, Andrew describes M&A work as a "team sport" in which the counsel team and client must work in concert to achieve a common goal, and notes that his biggest motivator is “wanting to do a good job for my clients and the team." Andrew was recently recognized by Law360 as a 2024 Mergers & Acquisitions Rising Star. #MandA
-
"Being at the forefront of working on legal matters that are defining moments for companies is such a blue ocean," Palo Alto partner Cassandra Gaedt-Sheckter tells Law360. "The work is always the culmination of a team effort, by my partners and associates, but also the in-house attorneys that I'm working with. I think maybe there's a sense of pride coming from being a part of that team." In the interview, Cassandra also discusses several of the prominent cases she has worked on, describes the global perspective of her practice, notes her interest and expertise in the California Consumer Privacy Act and the EU’s General Data Protection Regulation, and shares the value of hard work and the importance of learning in her practice. Cassandra is Co-Chair of our Artificial Intelligence Practice Group and was recently named a Cybersecurity/Privacy Rising Star by Law360. #AI #Cybersecurity
-
Our most recent DEI Task Force Update tracks key developments, media coverage, new and pending cases, and legislative developments in the DEI space. #DEI
-
Asked by City AM to comment on the U.K. government’s Arbitration Bill, which seeks to “support more efficient dispute resolution, attract international legal business [to London], and promote UK economic growth,” Gibson Dunn partner Piers Plumptre noted that “the Bill will be positive for London seated Arbitrations but will have very little impact on the London litigation market more broadly, which continues to thrive.” The bill was one of 40 new laws announced by the U.K. government in today’s King’s Speech. #Arbitration #UK #KingsSpeech
-
Associate Jonathan Lai has been named a Singapore Rising Star — one of “the country’s most promising legal talents” — by Asian Legal Business. Jonathan is a member of our International Arbitration and Litigation Practice Groups. Read more here: https://lnkd.in/gxV77XD3 #InternationalArbitration #Disputes #Asia #Singapore
-
-
Our lawyers review the California Supreme Court’s decision which held that courts must conduct a qualitative severance analysis even if they find multiple unconscionable provisions in an arbitration agreement. #California #Arbitration
-
Gibson Dunn is representing KBR in its acquisition of engineering company LinQuest Corporation for approximately $740 million. Our corporate team includes Houston partners Tull Florey and Cynthia Mabry and associates Ashley Whittington and Adri Langemeier. Partner Pamela Lawrence Endreny (New York) and associate Alissa Fromkin Freltz (Washington, D.C.) are advising on tax; partner Krista Hanvey and associate Lucy Hong (Dallas) on benefits; partner Sophia (Vandergrift) Hansell (Washington, D.C.) on antitrust; and partner Lindsay Paulin (Washington, D.C.) on government contracts. For more information, visit https://lnkd.in/ePss9pEf. #MandA
-
-
Writing in Financier Worldwide Magazine, Paris partner Ahmed Baladi and associate Thomas Baculard provide an overview of the European Union’s Data Act and explain its goals, obligations, and potential impact on data holders and users. To read the full article, go to https://lnkd.in/g-wxcgMZ. #DataAct #EU
Data Act – to share or not to share — Financier Worldwide
financierworldwide.com
-
The U.S. Food and Drug Administration (FDA) has issued its long-awaited draft guidance on Diversity Action Plans in clinical trials of drugs and devices. #FDA #Healthcare #LifeSciences #ClinicalTrial